Ethynylation of aryl halides by a modified Suzuki reaction: Application to the syntheses of combretastatin A-4, A-5 and lunularic acid

Liebigs Annales

Volumn , Issue 12, 1996, Pages 2107-2113

  Fürstner, Alois ^a   Nikolakis, Katharina ^a  

^a MAX PLANCK INSTITUT FÜR KOHLENFORSCHUNG   (Germany)

Author keywords

Alkynes; Chemo therapeutic agents; Combretastatin; Lunularic acid; Organoboron compounds; Palladium catalysis; Suzuki reaction

Indexed keywords

EID: 33748977642     PISSN: 09473440     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlac.199619961224     Document Type: Article

References (64)

1. For a review see: P. Potier, Chem. Soc. Rev. 1992, 92, 113-119.
2. [2a] Review: K. C. Nicolaou, W.-M. Dai, R. K. Guy, Angew. Chem. 1994, 106, 38-69;
3. Angew. Chem. Int. Ed. Engl. 1994, 33, 15.
4. [2b] For a recent highlight locating the taxol binding site on tubulin see: E. Nogales, S. G. Wolf, I. A. Khan, R. F. Luduena, K. H. Downing, Nature 1995, 375, 424-427.
5. Combretastatin A-4 and A-5: [3a] G. R. Pettit, S. B. Singh, E. Hamel, C. M. Lin, D. S. Alberts, D. Garcia-Kendall, Experientia 1989, 45, 209-211.
6. [3b] G. R. Pettit, S. B. Singh, M. R. Boyd, E. Hamel, R. K. Pettit, J. M. Schmidt, F. Hogan, J. Med. Chem. 1995, 38, 1666-1672.
7. [3c] C. M. Lin, H. H. Ho, G. R. Pettit, E. Hamel, Biochemistry 1989, 28, 6984-6991.
8. [3d] J. A. Woods, J. A. Hadfield, G. R. Pettit, B. W. Fox, A. T. McGown, Brit. J. Cancer 1995, 71, 705-711.
9. Other members of the combretastatin series: [4a] G. R. Pettit, S. B. Singh, Can. J. Chem. 1987, 65, 2390-2396.
10. [4b] G. R. Pettit, S. B. Singh, M. L. Niven, E. Hamel, J. M. Schmidt, J. Nat. Prod. 1987, 50, 119-131.
11. Review: D. L. Sackett, Pharmac. Ther. 1993, 59, 163-228.
12. [6a] G. R. Pettit, C. Temple, V. L. Narayanan, R. Varma, M. J. Simpson, M. R. Boyd, G. A. Rener, N. Bansal, Anti-Cancer Drug Design 1995, 10, 299-309.
13. [6b] R. T. Brown, B. W. Fox, J. A. Hadfield, A. T. McGown, S. P. Mayalarp, G. R. Pettit, J. A. Woods, J. Chem. Soc., Perkin Trans. 1 1995, 577-581.
14. [6c] S. B. Bedford, C. P. Quarterman, D. L. Rathbone, J. A. Slack, R. J. Griffin, M. F. G. Stevens, Bioorg. Med. Chem. Lett. 1996, 6, 157-160.
15. [6d] A. Ramacciotti, R. Fiaschi, E. Napolitano, Tetrahedron: Asymmetry 1996, 7, 1101-1104.
16. For leading references on combretastatin analogues see i.a.: [7a] Z. Getahun, L. Jurd, P. S. Chu, C. M. Lin, E. Hamel, J. Med. Chem. 1992, 35, 1058-1067.
17. [7b] M. Cushman, D. Nagarathnam, D. Gopal, H. M. He, C. M. Lin, E. Hamel, J. Med. Chem. 1992, 35, 2293-2306.
18. [7c] C. J. Andres, J. E. Bernardo, Q. Yan, S. B. Hastie, T. L. Macdonald, Bioorg. Med. Chem. Lett. 1993, 3, 565-570.
19. [7d] R. Shirai, K. Tokuda, Y. Koiso, S. Iwasaki, Bioorg. Med. Chem. Lett. 1994, 4, 699-704.
20. [7e] M. Medarde, R. Pelaez-Lamamie de Clairac, A. C. Ramos, E. Caballero, J. L. Lopez, D. G. Gravalos, A. San Feliciano, Bioorg. Med. Chem. Lett. 1995, 5, 229-232.
21. [7f] J. D. Olszewski, M. Marshalla, M. Sabat, R. J. Sundberg, J. Org. Chem. 1994, 59, 4285-4296.
22. Reviews: [8a] N. Miyaura, A. Suzuki, Chem. Rev. 1995, 95, 2457-2483.
23. [8b] A. Suzuki, Pure Appl. Chem. 1994, 66, 213-222.
24. [8c] A. Suzuki, Pure Appl. Chem. 1991, 63, 419-422.
25. [8d] A. Suzuki, Pure Appl. Chem. 1985, 57, 1749-1758.
26. [9a] A. Fürstner, G. Seidel, Tetrahedron 1995, 51, 11165-11176.
27. [9b] See also: J. A. Soderquist, K. Matos, A. Rane, J. Ramos, Tetrahedron Lett. 1995, 36, 2401-2402.
28. 3 as mediator for in situ Suzuki-type reactions of aryllithium compounds, c.f: [10a] W. A. Cristofoli, B. A. Keay, Tetrahedron Lett. 1991, 32, 5881-5884.
29. [10b] S. P. Maddaford, B. A. Keay, J. Org. Chem. 1994, 59, 6501-6503.
30. [10c] T. Gillmann, T. Hülsen, W. Massa, S. Wocadlo, Synlett 1995, 1257-1259.
31. 2O as external standard.
32. For leading references see: [12a] A. E. Stiegman, E. Graham, K. J. Perry, L. R. Khundkar, L.-T. Cheng, J. W. Perry, J. Am. Chem. Soc. 1991, 113, 7658-7666.
33. [12b] T. Hiyama, N. Wakasa, T. Ueda, T. Kusumoto, Bull. Chem. Soc. Jpn. 1990, 63, 640-642.
34. [12c] A. Scrivanti, U. Matteoli, Tetrahedron Lett. 1995, 36, 9015-9018.
35. [12d] E. Yashima, S. Huang, T. Matsushima, Y. Okamoto, Macromolecules 1995, 28, 4184-4193, and references cited therein.
36. For the use of trialkylethynylstannanes see: J. K. Stille, J. H. Simpson, J. Am. Chem. Soc. 1987, 109, 2138-2152.
37. For leading references on the use of ethynyltrimethylsilane see: [14a] S. Takahashi, Y. Kuroyama, K. Sonogashira, N. Hagihara, Synthesis 1980, 627-630.
38. [14b] W. B. Austin, N. Bilow, W. J. Kelleghan, K. S. Y. Lau, J. Org. Chem. 1981, 46, 2280-2286.
39. [14c] L. Brandsma, H. G. M. van den Heuvel, H. D. Verkruijsse, Synth. Commun. 1990, 20, 1889-1892.
40. [14d] T. Sakamoto, M. Shiraiwa, Y. Kondo, H. Yamanaka, Synthesis 1983, 312-314.
41. [14e] For the use of 2-methyl-3-butyn-2-ol as acetylene equivalent see: S. J. Havens, P. M. Hergenrother, J. Org. Chem. 1985, 50, 1763-1765.
42. 0 cat.) does not afford the corresponding ethynylarene but leads to the internal 1,2-diarylalkyne, see: [15a] K. Sonogashira, Y. Tohda, N. Hagihara, Tetrahedron Lett. 1975, 4467-4470.
43. [15b] M. Pal, N. G. Kundu, J. Chem. Soc., Perkin Trans. 1 1996, 449-451.
44. For the use of ethynylzinc halides see: A. O. King, E. I. Negishi, F. J. Villani, A. Silveira, J. Org. Chem. 1978, 43, 358-360.
45. Isolation and properties: [17a] I. F. M. Valio, R. S. Burdon, W. W. Schwabe, Nature 1969, 223, 1176-1178.
46. [17b] J. Gorham, Phytochemistry 1977, 16, 249-253.
47. [17c] J. Gorham, Phytochemistry 1978, 17, 99-105.
48. [17d] S. Abe, Y. Ohta, Phytochemistry 1983, 22, 1917-1920.
49. [17e] R. J. Pryce, Phytochemistry 1972, 11, 1355-1364.
50. Syntheses: [17f] Y. Arai, T. Kamikawa, T. Kubota, Tetrahedron Lett. 1972, 1615-1617.
51. [17g] T. Eicher, K. Tiefensee, R. Pick, Synthesis 1988, 525-529.
52. [17h] D. B. Reitz, S. M. Massey, J. Org. Chem. 1990, 55, 1375-1379.
53. [17i] Y. Arai, T. Kamikawa, T. Kubota, Y. Masuda, R. Yamamoto, Phytochemistry 1973, 12, 2279-2282.
54. [17j] S. Huneck, K. Schreiber, Phytochemistry 1977, 16, 1013-1016.
55. [18a] A. Hadfield, H. Schweitzer, M. P. Trova, K. Green, Synth. Commun. 1994, 24, 1025-1028.
56. [18b] See also: R. G. Dushin, S. J. Danishefsky, J. Am. Chem. Soc. 1992, 114, 655-659.
57. [18c] For the use of this triflate in the synthesis of a fungal metabolite with GABA-receptor inhibiting properties see: A. Fürstner, I. Konetzki, Tetrahedron, submitted.
58. [19a] 9-MeO-9-BBN: H. C. Brown, E. F. Knights, C. G. Scouten, J. Am. Chem. Soc. 1974, 96, 7765-7770. A 1 M solution in hexane can be purchased from Aldrich Chem. Co.
59. [19b] 9-BBN dimer: P. Binger, R. Köster, Inorg. Synth. 1974, 15, 147-149.
60. T. Hayashi, M. Konishi, Y. Kobori, M. Kumada, T. Higuchi, K. Hirotsu, J. Am. Chem. Soc. 1984, 106, 158-163.
61. [21a] M. Kato, F. Kido, M. D. Wu, A. Yoshikoshi, Bull. Chem. Soc. Jpn. 1974, 47, 1516-1521.
62. [21b] D. A. Dawson, W. F. Reynolds, Can. J. Chem. 1975, 53, 373-382.
63. [21c] A. I. Meyers, L. Snyder, J. Org. Chem. 1993, 58, 36-42.
64. [21d] S. Kano, T. Yakomatsu, S. Shibuya, J. Org. Chem. 1978, 43, 4366-4367.